SCHEMBL6538367

SCHEMBL6538367

CCc1cnc2c(NC(=O)c3c(Cl)cccc3Cl)cccc2c1-n1ccnc1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.40
CYP2D6 P10635 3/20 0.40
KCNH2 Q12809 2/20 0.40
GPR142 Q7Z601 2/20 0.40
JAK2 O60674 5/20 0.39
JAK1 P23458 5/20 0.39
TYK2 P29597 5/20 0.39
ITGB1 P05556 1/20 0.39
ITGA4 P13612 1/20 0.39
ITGB7 P26010 1/20 0.39
HTT P42858 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MEN1 O00255 1/20 0.39
CRHBP P24387 1/20 0.39
KMT2A Q03164 1/20 0.39
CRHR2 Q13324 1/20 0.39
CACNA1C Q13936 1/20 0.39
SCN5A Q14524 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6537417 0.87 TYK2 (0.40) CYP3A4CYP2D6KCNH2GPR142JAK2
SCHEMBL6537482 0.83 SMN1; SMN2 (0.46) CYP3A4CYP2D6KCNH2GPR142JAK2
SCHEMBL6538171 0.83 CYP3A4 (0.50) CYP3A4CYP2D6GPR142JAK2JAK1
SCHEMBL6538268 0.81 TYK2 (0.45) CYP3A4CYP2D6KCNH2GPR142JAK2
SCHEMBL8490281 0.78 HAVCR2 (0.44) CYP3A4JAK2JAK1TYK2HTT
SCHEMBL6537687 0.78 TYK2 (0.43) CYP3A4JAK2JAK1TYK2HTT
SCHEMBL6538343 0.78 SLC16A3 (0.46) CYP3A4JAK2JAK1TYK2ITGB1
SCHEMBL6537711 0.77 TYK2 (0.42) CYP3A4JAK2JAK1TYK2HTT
SCHEMBL6537622 0.77 TYK2 (0.42) CYP3A4JAK2JAK1TYK2HTT
SCHEMBL6537772 0.77 TYK2 (0.42) CYP3A4JAK2JAK1TYK2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed